Condition: Focal Seizures · Sponsor: Jazz Pharmaceuticals
Cannabidiol oral solution (CBD-OS) is approved in the US for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or Tuberous sclerosis complex (TSC) in patients 1 year of age and older. This study will assess the efficacy and safety of CBD-OS in participants aged 12 to 75 years for the treatment of focal-onset seizures (FOS).
This description comes directly from the study's public registry record.
Clinical Trial Disclosure & Transparency · 215-832-3750 · ClinicalTrialDisclosure@JazzPharma.com
Always discuss trial participation with your own doctor first.
| Banner University Medical Center-Phoenix | Phoenix, Arizona, United States | Not Yet Recruiting |
| UC San Diego | La Jolla, California, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Savannah Neurology Specialists | Savannah, Georgia, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| Mid-Atlantic Epilepsy and Sleep Center | Bethesda, Maryland, United States | Recruiting |
| Wayne State University | Detroit, Michigan, United States | Not Yet Recruiting |
| Corewell Health | Grand Rapids, Michigan, United States | Not Yet Recruiting |
| Hackensack Meridian Neuroscience Institute at JFK University Medical Center | Edison, New Jersey, United States | Not Yet Recruiting |
| Saint Peter's University Hospital | New Brunswick, New Jersey, United States | Recruiting |
+ 12 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07233239